LOGIN  |  REGISTER
Terns Pharmaceuticals
Terns Pharmaceuticals

DocGo to Participate in the iAccess Alpha Buyside Best Ideas Summer Conference 2024 on June 25 and 26, 2024

June 20, 2024 | Last Trade: US$4.25 0.03 0.71

NEW YORK / Jun 20, 2024 / Business Wire / DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that management is participating in the iAccess Alpha Buyside Best Ideas Summer Conference 2024 on June 25 and 26, 2024. Lee Beinstock, DocGo’s Chief Executive Officer, will deliver a company presentation at 2:00 PM Eastern Time on June 25 and host one-on-one meetings the following day, June 26.

iAccess Alpha hosts virtual investor conferences, where presenting companies are recommended by a network of investors. The conference format spans two days, with company webcast presentations on day one, followed by one-on-one meetings with company management teams on day two.

To learn more about the iAccess Alpha Buyside Best Ideas Summer Conference 2024 on June 25 and 26, 2024 or to register and schedule a one-on-one meeting with DocGo, please visit the conference website https://www.iaccessalpha.com/home.

The presentation will be webcast live and available for replay here.

The webcast of DocGo’s presentation will also be available on the investor relations section of DocGo’s website at https://ir.docgo.com/.

About DocGo

DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo is helping to reshape the traditional four-wall healthcare system by providing high quality, highly accessible care to patients where and when they need it. DocGo’s proprietary technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient’s home or workplace. Together with DocGo’s integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com.

Astria Therapeutics

Stock Quote

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page